Objective: Inferior survival outcomes have historically been reported for African Americans with cardiovascular disease, and poorer outcomes have been presumed for peripheral arterial disease (PAD) as well. The current study evaluates the effect of race and ethnicity on survival of patients undergoing open or endovascular interventions for lower extremity PAD. Combining all procedures, overall mortality was lower among African Americans than among white Americans (12.4% vs 14.2%; P < .0001) but not death in the periprocedural period (1.1% vs 1.2%; P ¼ .26). To account for differences in length of follow-up, Cox proportional hazards analysis confirmed that the African American race was independently associated with a significantly lower occurrence of overall mortality after INFRA bypass (hazard ratio [HR], 0.78; 95% confidence interval [CI], 0.70-0.88; P < .0009), InfraPVI (HR, 0.72; 95% CI, 0.67-0.78; P < .0001), and SupraPVI (HR, 0.77; 95% CI, 0.66-0.90; P ¼ .0009) interventions but not after SUPRA bypass or AMP. Similarly, by Cox proportional hazards, Hispanic/Latino ethnicity was also independently associated with lower overall mortality after INFRA bypass (HR, 0.75; 95% CI, 0.62-0.91; P ¼ .0030), InfraPVI (HR, 0.69; 95% CI, 0.62-0.78; P < .0001), and SupraPVI (HR, 0.68; 95% CI, 0.52-0.89; P ¼ .0045) but not after SUPRA bypass or AMP.
Multiple studies have shown racial disparities in the outcomes of treatment for atherosclerosis, including intervention for peripheral arterial disease (PAD), with worse outcomes, such as amputation or mortality rates, experienced by African Americans. [1] [2] [3] [4] Most have indicated that socioeconomic factors appear to play a much larger role than any biologic factors, demonstrating the necessity for improving access to care and medical management of disease. Whereas such issues are undoubtedly pertinent and appropriate, using the Society for Vascular Surgery Vascular Quality Initiative (SVS VQI) database cross-checked by the Social Security Death Index (SSDI), a recent study designed to predict the outcomes of open surgical and endovascular intervention for infrapopliteal severe limb ischemia suggested better survival at 1 year for patients identified as African American. 5 In addition, a prior populationbased study using the South Carolina database also suggested a survival advantage enjoyed by African American patients with PAD despite the observation that major adverse limb events were more frequent among African Americans. 6 As these survival advantages for African Americans treated for infrapopliteal critical limb ischemia appear to run counter to prior reports, it would be important to determine whether this applies to other patterns of PAD. If true, such findings would indicate the need to determine what factors might be responsible to try to extend such advantages to all.
The purpose of the current study was to use national data from the SVS VQI to determine whether there is a survival advantage in African American patients undergoing various interventions for peripheral arterial occlusive disease. The hypothesis to be tested was that African American patients would demonstrate better overall survival than white patients after open surgical or endovascular intervention for PAD in the immediate postprocedural and follow-up periods.
METHODS
Database. The SVS VQI registry that includes demographic, symptom, physiologic, anatomic imaging, surgical and interventional, and outcomes information was the source for the current study after approval by the SVS Research Advisory Committee. This registry includes data starting in January 2003 from the Vascular Study Group of New England. Data were provided in an unlinked, deidentified manner and were deemed to be exempt from further human use review in concordance with the Declaration of Helsinki by the Institutional Review Board of the Medical University of South Carolina, the sponsoring institution for this work. The requirement for patient informed consent was waived. Validation of registry data is performed by comparison with claims data provided by participants based on Current Procedural Terminology codes or International Classification of Diseases, Ninth Revision and now International Classification of Diseases, Tenth Revision codes, with inconsistencies rectified. Mortality was determined by cross-checking with the SSDI, which should minimize concerns of incomplete follow-up for mortality within the SVS VQI registry.
Study design. Data were initially stratified according to currently available modules within the registry, specifically "Peripheral Vascular Intervention" (PVI), "Infrainguinal Bypass" (INFRA bypass), "Supra-inguinal Bypass" (SUPRA bypass), and "Lower Extremity Amputation" (AMP). The PVI group was stratified into two subgroups, suprainguinal (SupraPVI) and infrainguinal (InfraPVI), according to whether any of the three interventions first listed included the aorta or iliac vessels. Data included demographics of the patients, indication for intervention, comorbidities, risk factors, laboratory values (creatinine, hemoglobin where available), vascular anatomy, physiologic parameters, number and site of lesions treated, type of treatment, conduit type (if used), and perioperative complications including myocardial infarction or death at any time. Creatinine concentration, body mass index (BMI), hemoglobin level, and length of disease were categorized as being above, below, or within normal ranges because of non-Gaussian distribution. It was uncommon for periprocedural data to be missing. Specifically, this was most often observed for BMI (height/weight), angiotensin-converting enzyme inhibitor use, and TransAtlantic Inter-Society Consensus classification. Therefore, patients with incomplete data were excluded from analysis. In addition, patients who were listed as being "asymptomatic" were excluded. The primary end point was survival of the patient, specifically the field "DEAD" ¼ 1. Because the VQI data are cross-referenced with the SSDI, all patients were included in the mortality analysis, regardless of entry of 1-year follow-up data. Although SVS VQI follow-up is entered from 9 to 22 months after the procedure, using the SSDI, the overall mortality is determined at any time.
Statistics. Both univariate and multivariate analyses were performed. For the univariate analyses, either unpaired, two-sided Student t-tests or c 2 test analyses were employed, depending on the variable structure (ie, continuous or binary). Univariate analysis identified important prognostic variables to be used in the multivariate regression analysis. For the end point of overall mortality, Cox proportional hazards model was employed, with backward removal of variables for P < .05. (Tables I-III) . Univariate analysis revealed significant differences in the frequency of many of these variables between African American and white patients, the nature of which differed according to the type or location of the procedure. Combining all procedures, overall mortality was lower among African Americans than among white Americans (12.4% vs 14.2%; P < .0001), but not periprocedural death ( (Fig 6) . Testing for interaction effects based on race plus age, BMI, or gender failed to demonstrate any interaction, further suggesting that the effect of race was not due to association with these variables.
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DISCUSSION
This study using national data has demonstrated the likelihood of a survival advantage to African Americans over white Americans undergoing intervention for infrainguinal arterial occlusive disease as well as a similar survival advantage for Hispanic/Latino ethnicity. Interestingly, no survival advantage (or disadvantage) was noted for patients undergoing intervention for suprainguinal disease or for lower extremity amputation. These observations from the SVS VQI database are contrary to numerous studies that have demonstrated worse outcomes for African Americans with cardiovascular disease including PAD. 3, 4, [7] [8] [9] [10] Lower rates of limb salvage have been noted after intervention, which was interpreted to be related to advanced ischemia at the time of presentation. 2 Even the updated report by the American Heart
Association of the status of cardiovascular disease in the United States echoes this finding. 1 Compared with an age-adjusted death rate for PAD of 18.1 per 100,000 overall average, a death rate is reported in men of 21.6 for whites vs 24.7 for African Americans and in women of 15.7 for whites vs 18.3 for African Americans. The reasons for the survival advantage in the current study and the explanation for the observation that this advantage appears to be limited to patients with primarily infrainguinal disease remain elusive. Although diabetes mellitus, congestive heart failure, renal insufficiency, anemia, nonambulatory state, elevated American Society of Anesthesiologists class, and critical limb ischemia are associated with increased risk of mortality during followup by multivariate analysis, all of these risk factors were actually higher in African Americans. Preoperative use of statins and antiplatelet agents was lower among African Americans treated for infrainguinal disease, and although this analysis certainly does point to an opportunity to improve provision of statin and antiplatelet medications in this population, lack of appropriate medical therapy does not account for the improved survival of patients observed. Others have noted higher rates of insulindependent diabetes mellitus, hypertension, critical limb ischemia, dialysis dependence, and lower albumin levels, the first three of which were also observed in the current study, although the lower age at presentation of African Americans in their study did not reach statistical significance as it did in the current report. 2 In fact, the severity of infrapopliteal arterial occlusive disease has been known for some time to be significantly greater by arteriographic staging in African American men. 11 In addition, it has been observed that African Americans are less likely to undergo revascularization procedures instead of primary amputation. 5, 6, 12, 13 On the other hand, other risk factors found to be associated with increased mortality during follow-up, such as increased age, male gender, coronary artery disease, chronic obstructive pulmonary disease, and Hispanic ethnicity, were less common among African Americans. Still, the statistical methods used in the current study should eliminate the contribution of these differences in the analysis of mortality by race, and no interaction effect was detected with these variables or with BMI. However, other important factors that may contribute to survival of the patient, such as albumin level or tests of liver function or measures of patient frailty such as falls at home or central sarcopenia, are not captured by the SVS VQI database, so racial/ethnicity differences in these factors cannot be assessed. Certainly, with African Americans experiencing disadvantaged outcomes for many other conditions in this country, including cardiovascular disease, it would be valuable to identify the factors responsible for this survival advantage. If this were possible, it might be feasible to apply these factors to other forms of vascular disease. However, any such factors remain hidden at this point. Any of the adverse socioeconomic factors, such as those previously thought to play a role in the higher postoperative mortality in other forms of cardiovascular disease, do not appear to play a strongly negative role for patients undergoing open or endovascular intervention for infrainguinal disease. This would appear to be counterintuitive, as the prolonged recovery frequently observed with patients undergoing open surgical revascularization for PAD would seem to demand significant social and financial support at home or in rehabilitation, which would be less available to patients with socioeconomic impediments to access to care. In addition, as the one available measure of a patient's socioeconomic status, the presence of Medicaid or self-pay status appeared to play no role in survival compared with other types of medical insurance, with the highest mortality on multivariate analysis observed with Medicare beneficiaries. Unfortunately, any other independent factors that might actually be associated with the improved survival of African Americans (eg, psychosocial, social, economic) are not collected by the SVS VQI database. Zip code data to attempt to ascertain either regional or socioeconomic influences on survival of patients was withheld by the SVS VQI. It was noted that follow-up was shorter on average for African Americans because of a lower proportion of African Americans being included in the early years of the SVS VQI database. Whereas the Cox proportional hazards analysis addressed length of follow-up, the year that the procedure was performed was not included as a variable, and it is possible that if mortality was significantly improved in the later years for infrainguinal (but not suprainguinal) open or endovascular interventions, this could bias the interpretation of the study. One might postulate that differences in mortality might be a form of self-selection. That is, perhaps there might be a tendency for less healthy African Americans to decline intervention for their peripheral vascular disease, skewing the overall health status of the population at risk undergoing intervention.
14 There may be reluctance of members of one racial/ethnic group to acknowledge, accept, or agree to the recommendation of vascular specialists who belong to a different racial/ ethnic group. In one recent survey, discussion of all treatment options for PAD tended to be more often preferred by African Americans than by white Americans than discussion of only the surgeon's recommended treatment. In addition, African Americans also had a different perspective on the outcome and considered their initial treatments to be less successful (21% vs 57%; P ¼ .003) and none of their treatments to be at all successful (29% vs 11%; P ¼ .052) compared with white Americans. 15 On the other hand, racial bias on the part of a health care provider has been implicated in offering treatment for PAD. 12, 13 Might it be possible that reluctance to pursue aggressive efforts at revascularization in poorer operative candidates who happen to be African American might have the unintentional effect of selecting out the less healthy candidates for revascularization and have the unintended consequence of improving average longer-term survival for those African Americans who actually do undergo infrainguinal procedures? Such an interplay might also account for the lower overall mortality observed in this study for Hispanic/Latino patients as well. Interestingly, rising morbidity and mortality in midlife have been noted among white, non-Hispanic Americans in the current century compared with African Americans, primarily because of drug and alcohol poisonings, suicide, and chronic liver disease and cirrhosis that have not been witnessed in most European nations. 16 Although mortality was higher for whites in the current study, the reasons for death were not recorded, and other conditions beyond cardiovascular death may apply. Nonetheless, the current study does not provide any direct evidence to support this theory.
There are a number of other limitations to the current study. The first is that although data are prospectively entered into the VQI, there is no formalized third-party audit of the data entered. With the exception of PVI procedures performed in conjunction with a femoral endarterectomy, hybrid procedures such as simultaneous SUPRA and INFRA bypasses or SupraPVI in conjunction with an INFRA bypass would be counted as separate procedures. In addition, because of the manner of assignment, some SupraPVI procedures may also have had InfraPVI interventions performed that were not included. Follow-up can be incomplete in the VQI, as acknowledged by the registry to be as high as 68% from 2012 and 45% from 2013 (report by SVS Patient Safety Organization Governing Council). However, because mortality of patients is cross-referenced with the SSDI, it is expected that very few patient deaths were omitted. Nonetheless, the VQI database registry does represent the experience of a wide variety of practitioners and institutions committed to improving quality in the care of patients with peripheral vascular disease and can offer value for studies such as the current one.
CONCLUSIONS
Contrary to the published data for other forms of cardiovascular disease, African American patients with PAD included in the SVS VQI undergoing INFRA bypass or PVI for lower extremity PAD enjoyed better survival compared with white Americans. The reasons for this remain unclear, although the possibility exists for selection bias on the part of the patients or the providers, with healthier African American patients undergoing revascularization instead of primary amputation.
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